Skip to content

Net Income at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$13.35M+68.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$4.93M+63.7%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$186.6M+501%
Zymeworks logo
ZymeworksZYME
-$44.16M-95.1%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$185M-22.5%
ALN
Alnylam PharmaceuticalsALNY
$205.99M+1,229%

Segments

By segment

See full
Single Reportable$4.47M+88.6%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's net income?
XOMA Corporation (XOMA) reported net income of $4.47M in Q1 2026.
How has XOMA Corporation's net income changed year-over-year?
XOMA Corporation's net income increased by 88.6% year-over-year, from $2.37M to $4.47M.
What is the long-term trend for XOMA Corporation's net income?
Over 4 years (2021 to 2025), XOMA Corporation's net income has grown at a 19.0% compound annual growth rate (CAGR), from $15.8M to $31.71M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.